The authors have no conflicts of interest to declare.
Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients†
Article first published online: 7 APR 2011
Copyright © 2011 Wiley-Liss, Inc.
Journal of Surgical Oncology
Special Issue: The Pivotal Role of the Lymphovascular System in Cancer Metastasis
Volume 103, Issue 6, pages 531–533, 1 May 2011
How to Cite
Viehl, C. T., Langer, I., Guller, U., Zanetti-Dällenbach, R., Moch, H., Wight, E., Oertli, D. and Zuber, M. (2011), Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J. Surg. Oncol., 103: 531–533. doi: 10.1002/jso.21693
- Issue published online: 7 APR 2011
- Article first published online: 7 APR 2011
- Manuscript Accepted: 13 JUL 2010
- Manuscript Received: 31 MAY 2010
- breast cancer;
- axillary lymph node dissection;
- sentinel lymph node procedure;
- lymphatic micrometastasis;
- treatment outcome
The prognostic value of sentinel lymph node (SLN) micro-metastases and the question whether patients with SLN micro-metastases should undergo axillary lymph node dissection remain a matter of great debate. Based on the current literature and on our own data, we provide suggestive evidence that SLN micro-metastases in early stage breast cancer patients appear to have prognostic value and should impact the decision-making regarding adjuvant therapy, however, do not necessarily require further surgical treatment. J. Surg. Oncol. 2011;103:531–533. © 2011 Wiley-Liss, Inc.